Inventor · disambiguated record
Claire L. Sutherland
Also filed as: SUTHERLAND CLAIRE · SUTHERLAND CLAIRE L
4 granted patents·7 pending applications·18 citations·filing 2017–2024
71Inventor score
Files withJUNO THERAPEUTICS INC11
Top patents by PatentIndex Score
11 records- 0192US11944647B2Articles of manufacture and methods for treatment using adoptive cell therapyJUNO THERAPEUTICS INC·Filed 2022·Granted Apr 2, 2024·5 cites·20 claims
- 0292US11413310B2Articles of manufacture and methods for treatment using adoptive cell therapyJUNO THERAPEUTICS INC·Filed 2018·Granted Aug 16, 2022·12 cites·55 claims
- 0378US2024115612A1Articles of manufacture and methods for treatment using adoptive cell therapyJUNO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0475US12161670B2Phenotypic markers for cell therapy and related methodsJUNO THERAPEUTICS INC·Filed 2018·Granted Dec 10, 2024·1 cites·20 claims
- 0569US2025059253A1Phenotypic markers for cell therapy and related methodsJUNO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0647US2021071258A1Gene expression and assessment of risk of developing toxicity following cell therapyJUNO THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 0746US2022088070A1Methods for treatment using adoptive cell therapyJUNO THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0844US2021198372A1Methods for dosing and for modulation of genetically engineered cellsJUNO THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 0939US12163952B2Determining toxicity risk in CAR T-cell therapyJUNO THERAPEUTICS INC·Filed 2018·Granted Dec 10, 2024·0 cites·28 claims
- 1038US2024018268A1Anti-idiotypic antibodies against anti-cd19 antibodiesJUNO THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1138US2020078400A1Methods for determining car-t cells dosingJUNO THERAPEUTICS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Claire L. Sutherland files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →